Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mimi Y Kim

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Obesity (Silver Spring, Md.)|March 31, 2016
Common scientific and statistical errors in obesity researchBrandon J George, T Mark Beasley, Andrew W Brown, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 13, 2017
Kidney Outcomes and Risk Factors for Nephritis (Flare/<i>De Novo</i>) in a Multiethnic Cohort of Pregnant Patients with LupusJill P Buyon, Mimi Y Kim, Marta M Guerra, et al.
Cancer Causes & Control : CCC|February 22, 2019
Metabolic syndrome and risk of endometrial cancer in postmenopausal women: a prospective studyRhonda S Arthur, Geoffrey C Kabat, Mimi Y Kim, et al.
American Journal of Obstetrics and Gynecology|October 4, 2015
Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE studyMimi Y Kim, Jill P Buyon, Marta M Guerra, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 28, 2020
Leveraging the United States Epicenter to Provide Insights on COVID-19 in Patients With Systemic Lupus ErythematosusRuth Fernandez-Ruiz, Mala Masson, Mimi Y Kim, et al.
Rheumatology (Oxford, England)|March 17, 2009
Expression of endothelial protein C receptor in cortical peritubular capillaries associates with a poor clinical response in lupus nephritisPeter M Izmirly, Laura Barisoni, Jill P Buyon, et al.
Annals of the Rheumatic Diseases|October 24, 2023
Prevalence of clinically meaningful antiphospholipid antibodies in patients with systemic lupus erythematosus varies by race and ethnicityCécile M Yelnik, Xianhong Xie, Marta M Guerra, et al.
Arthritis and Rheumatism|April 15, 2010
Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trialDeborah M Friedman, Carolina Llanos, Peter M Izmirly, et al.
Annals of Internal Medicine|June 22, 2005
The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trialJill P Buyon, Michelle A Petri, Mimi Y Kim, et al.
The Journal of Experimental Medicine|March 30, 2021
Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosusJohannes Hartl, Lee Serpas, Yueyang Wang, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Obesity (Silver Spring, Md.)|March 31, 2016
Common scientific and statistical errors in obesity researchBrandon J George, T Mark Beasley, Andrew W Brown, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 13, 2017
Kidney Outcomes and Risk Factors for Nephritis (Flare/<i>De Novo</i>) in a Multiethnic Cohort of Pregnant Patients with LupusJill P Buyon, Mimi Y Kim, Marta M Guerra, et al.
Cancer Causes & Control : CCC|February 22, 2019
Metabolic syndrome and risk of endometrial cancer in postmenopausal women: a prospective studyRhonda S Arthur, Geoffrey C Kabat, Mimi Y Kim, et al.
American Journal of Obstetrics and Gynecology|October 4, 2015
Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE studyMimi Y Kim, Jill P Buyon, Marta M Guerra, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 28, 2020
Leveraging the United States Epicenter to Provide Insights on COVID-19 in Patients With Systemic Lupus ErythematosusRuth Fernandez-Ruiz, Mala Masson, Mimi Y Kim, et al.
Rheumatology (Oxford, England)|March 17, 2009
Expression of endothelial protein C receptor in cortical peritubular capillaries associates with a poor clinical response in lupus nephritisPeter M Izmirly, Laura Barisoni, Jill P Buyon, et al.
Annals of the Rheumatic Diseases|October 24, 2023
Prevalence of clinically meaningful antiphospholipid antibodies in patients with systemic lupus erythematosus varies by race and ethnicityCécile M Yelnik, Xianhong Xie, Marta M Guerra, et al.
Arthritis and Rheumatism|April 15, 2010
Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trialDeborah M Friedman, Carolina Llanos, Peter M Izmirly, et al.
Annals of Internal Medicine|June 22, 2005
The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trialJill P Buyon, Michelle A Petri, Mimi Y Kim, et al.
The Journal of Experimental Medicine|March 30, 2021
Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosusJohannes Hartl, Lee Serpas, Yueyang Wang, et al.
Pageof 9